18142129. GLYCOENGINEERING simplified abstract (The General Hospital Corporation)
Contents
- 1 GLYCOENGINEERING
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 GLYCOENGINEERING - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 How does glycoengineering compare to other therapeutic approaches in terms of efficacy and safety?
- 1.11 What are the regulatory challenges associated with implementing glycoengineering in therapeutic applications?
- 1.12 Original Abstract Submitted
GLYCOENGINEERING
Organization Name
The General Hospital Corporation
Inventor(s)
Robert M. Anthony of Arlington MA (US)
Maya Kitaoka of Arlington MA (US)
GLYCOENGINEERING - A simplified explanation of the abstract
This abstract first appeared for US patent application 18142129 titled 'GLYCOENGINEERING
Simplified Explanation
The patent application relates to glycoengineering for therapeutic purposes.
- Glycoengineering methods for therapeutic applications
- Utilization of glycoengineering in various therapeutic purposes
Potential Applications
Glycoengineering can be applied in:
- Developing new drugs with enhanced therapeutic effects
- Improving the efficacy of existing therapeutics
Problems Solved
This technology addresses:
- Limitations in current therapeutic options
- Challenges in drug delivery and targeting specific cells
Benefits
The benefits of this technology include:
- Enhanced treatment outcomes
- Reduced side effects
- Improved patient quality of life
Potential Commercial Applications
This technology could be utilized in:
- Pharmaceutical industry for drug development
- Biotechnology companies for therapeutic innovations
Possible Prior Art
Prior research in glycoengineering for therapeutic purposes includes:
- Studies on modifying glycan structures for improved drug delivery
- Research on glycosylation patterns in disease states
Unanswered Questions
How does glycoengineering compare to other therapeutic approaches in terms of efficacy and safety?
Glycoengineering offers unique advantages in terms of specificity and targeting compared to traditional therapeutics, but further comparative studies are needed to fully understand its benefits.
What are the regulatory challenges associated with implementing glycoengineering in therapeutic applications?
Regulatory approval processes for novel therapeutic approaches like glycoengineering may pose challenges due to the need for demonstrating safety and efficacy in clinical trials.
Original Abstract Submitted
This disclosure relates to glycoengineering, and methods of utilizing glycoengineering for various therapeutic purposes.
